default author photo

Jesús Castilla

Instituto de Salud Pública y Laboral de Navarra

Spain

SCHOLARLY PAPERS

4

DOWNLOADS

576

TOTAL CITATIONS

4

Scholarly Papers (4)

1.

Nirsevimab Effectiveness Against Rsv Hospital Admission in Children Under 1 Year of Age: A Spanish Population-Based Case Control Study

Number of pages: 28 Posted: 15 Aug 2024
Carlos III Institute of Health, Madrid Ministry of Health - Vaccines Division, Regional University Hospital – IBIMA, Consejería de Sanidad - Dirección General de Salud Pública, Subdirectorate of Epidemiology and Public Health Surveillance, Subdirectorate of Epidemiology and Public Health Surveillance, Consejería de Sanidad - Dirección General de Salud Pública, Health Services Research Network in Chronic Diseases (REDISSEC), Department of Health, Department of Health, Generalitat de Catalunya, Generalitat de Catalunya - Department of Health, Consejería de Sanidad - Dirección General de Salud Pública, Madrid Ministry of Health - General Directorate of Public Health, Public Health Directorate, Public Health Directorate, Canary Islands Health Service, Canary Islands Health Service, Public Health Directorate, Public Health Directorate, Madrid Ministry of Health - General Directorate of Public Health, Madrid Ministry of Health - General Directorate of Public Health, Hospital Universitari Son Espases, Hospital Universitari Son Espases, Madrid Ministry of Health - General Directorate of Public Health, Madrid Ministry of Health - General Directorate of Public Health, Consejería de Sanidad - Dirección General de Salud Pública, Consejería de Sanidad - Dirección General de Salud Pública, Instituto de Salud Pública y Laboral de Navarra, Consejería de Sanidad - Dirección General de Salud Pública, Consejería de Sanidad - Dirección General de Salud Pública, Consejería de Sanidad - Dirección General de Salud Pública, Consejería de Sanidad - Dirección General de Salud Pública, Consejería de Sanidad - Dirección General de Salud Pública, University Hospital of Melilla, University Hospital of Melilla, Consejería de Sanidad - Dirección General de Salud Pública, Consejería de Sanidad - Dirección General de Salud Pública, University Hospital of Ceuta, University Hospital of Ceuta, Carlos III Institute of Health - National Center for Epidemiology, Consejería de Sanidad - Dirección General de Salud Pública, Carlos III Health Institute and Carlos III Institute of Health - Communicable Diseases Department
Downloads 175 (431,126)

Abstract:

Loading...

Respiratory Syncytial Virus, Hospitalization, Nirsevimab, effectiveness, Observational Study.

2.

Global Serotype Distribution of Remaining Invasive Pneumococcal Disease after Extensive Use of Pcv10/13: The Pserenade Project

Number of pages: 59 Posted: 13 Mar 2024
Emory University - Rollins School of Public Health, Johns Hopkins University - Bloomberg School of Public Health, Johns Hopkins University - Bloomberg School of Public Health, Johns Hopkins University - International Vaccine Access Center, Johns Hopkins University - Department of Epidemiology, Johns Hopkins University - Bloomberg School of Public Health, Johns Hopkins University - Bloomberg School of Public Health, Johns Hopkins University - Department of International Health, International Vaccine Access Center, World Health Organization (WHO) - Department of Immunizations, Vaccines and Biologicals, University of the Witwatersrand - Department of Clinical Microbiology and Infectious Diseases, RWTH Aachen University - RWTH University Hospital Aachen, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, Consejería de Sanidad - Servicio de Epidemiología, Yale University - Institute for Global Health, affiliation not provided to SSRN, Centers for Disease Control & Prevention - National Center for Immunization and Respiratory Diseases, Centre Hospitalier Intercommunal de Créteil, Statens Serums Institut - Infectious Disease Epidemiology & Prevention, University of West Attica, National Institute of Public Health, affiliation not provided to SSRN, World Health Organization (WHO), Government of the United Kingdom - NHS Greater Glasgow and Clyde, London School of Hygiene & Tropical Medicine, Epiconcept, Riga Stradins University, University of Melbourne - Murdoch Children's Research Institute, World Health Organization (WHO), Toyama Institute of Health - Department of Bacteriology, Tampere University - Faculty of Social Sciences, INEI - ANLIS “Dr. Carlos G. Malbrán" - Servicio de Bacteriología Clínica, World Health Organization’s Regional Office for Africa, Hospital Sant Joan de Deu - Molecular Microbiology Department, Public Health Agency of Sweden, Australian Government - Centre for Disease Control, University of Toronto, Regional Authority of Public Health - National Reference Centre for Pneumococcal and Haemophilus Diseases, London School of Hygiene & Tropical Medicine - Medical Research Council Unit: The Gambia, LACEN - Laboratório Central de Saúde Pública, Public Health England - Immunisation and Countermeasures Division, Landspitali - The National University Hospital - Department of Clinical Microbiology, National Institute of Public Health, National Health Laboratory Services (NHLS) - Centre for Respiratory Diseases and Meningitis, Kaiser Permanente Northern California - Kaiser Permanente Vaccine Study Center, University of Calgary, The University of Sydney, The University of Hong Kong - Department of Microbiology, University of Bern, Government of the United States of America - Arctic Investigations Program, Johns Hopkins University - Department of International Health, International Vaccine Access Center, National Institute of Public Health, ESR (Institute of Environmental Science and Research) - Health Intelligence Team, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, University of Liverpool, Mohammed VI University of Health Sciences, KU Leuven - University Hospitals Leuven, Université Laval, Statens Serums Institut, Ben-Gurion University of the Negev - Faculty of Health Science, Children’s Health Ireland at Temple Street - Irish Meningitis and Sepsis Reference Laboratory, European Centre for Disease Prevention and Control, Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud, Instituto de Salud Pública y Laboral de Navarra, Italian National Institute of Health, National Centre for Infectious Diseases (Singapore), University of Utah Health Sciences Center - Division of Pediatric Infectious Diseases, Instituto Adolfo Lutz, Instituto de Salud Pública de Chile, Johns Hopkins University - Department of International Health, International Vaccine Access Center and Independent
Downloads 152 (488,442)
Citation 1

Abstract:

Loading...

IPD, PCV impact, global, serotype distribution, all ages

3.

Effectiveness of Covid-19 Vaccines Administered in the 2023 Autumnal Campaigns in Europe: Results from the Vebis Primary Care Test-Negative Design Study, September 2023–January 2024

Number of pages: 27 Posted: 01 May 2024
Epiconcept, National Institute of Health Doutor Ricardo Jorge, Epiconcept, Carlos III Institute of Health - Communicable Diseases Department, Robert Koch Institute, Health Service Executive, Semmelweis University, Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP, National Health Institute Doutor Ricardo Jorge (INSA) - Epidemiology Department, Universidad Pública de Navarra - IdiSNA, Navarra Institute for Health Research, National Institute for Public Health and the Environment (RIVM) - Centre for Infectious Disease Control, Croatian Institute of Public Health, Public Health Agency of Sweden, Romanian Institute of Science and Technology - National Institute of Research and Development for Microbiology and Immunology „Cantacuzino”, Carlos III Health Institute, Robert Koch Institute, University College Dublin (UCD), Semmelweis University, University of Paris-Saclay - Laboratoire de Microbiologie, National Health Institute Doutor Ricardo Jorge (INSA) - National Influenza Reference Laboratory, Instituto de Salud Pública y Laboral de Navarra, NIVEL (Netherlands Institute for Health Services Research), Croatian Institute of Public Health, Public Health Agency of Sweden, National Institute for Public Health and the Environment (RIVM), National Health Institute Doutor Ricardo Jorge (INSA) - Bioinformatics Unit, Consejería de Sanidad, European Centre for Disease Prevention and Control, European Centre for Disease Prevention and Control and Epiconcept
Downloads 137 (534,155)
Citation 2

Abstract:

Loading...

COVID-19, vaccine effectiveness, multicentre study, test-negative design, Europe, SARS-CoV-2

4.

The Potential Bias Introduced into COVID-19 Vaccine Effectiveness Studies at Primary Care Level Due to the Availability of SARS-CoV-2 Tests in the General Population

Number of pages: 28 Posted: 12 Nov 2024
Epiconcept, Epiconcept, Carlos III Institute of Health - Communicable Diseases Department, National Institute for Public Health and the Environment (RIVM), Semmelweis University, National Institute of Health Doutor Ricardo Jorge, Public Health Agency of Sweden, Croatian Institute of Public Health, Cantacuzino National Military Medical Institute for Research and Development, Consejería de Sanidad - Dirección General de Salud Pública, Robert Koch Institute - Department for Infectious Disease Epidemiology, Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP, Health Service Executive, Universidad Pública de Navarra - IdiSNA, Navarra Institute for Health Research, NIVEL (Netherlands Institute for Health Services Research), Semmelweis University, National Health Institute Doutor Ricardo Jorge (INSA) - National Influenza Reference Laboratory, Public Health Agency of Sweden, Croatian Institute of Public Health, Cantacuzino National Military Medical Institute for Research and Development, Consejería de Sanidad - Dirección General de Salud Pública, Robert Koch Institute, Université Paris Saclay, Health Service Executive, Instituto de Salud Pública y Laboral de Navarra, National Institute for Public Health and the Environment (RIVM), National Institute for Public Health and the Environment (RIVM), European Centre for Disease Prevention and Control, European Centre for Disease Prevention and Control and Epiconcept
Downloads 112 (630,858)
Citation 1

Abstract:

Loading...

COVID-19, Vaccine effectiveness, Test-negative design, Self-test, Bias, Directed acyclic graph, Simulation